The draft guidance document provides advice to industry on how to use minimal residual disease as a biomarker in clinical trials of hematologic...
Quality and access to care issues were raised by MedPAC officials and physician groups.
But market corrections, not federal government action, may be driving the declines.
Oncologists say a new company that aims to link patients with cancer care and clinical trials through technology has both positives and negatives...
Health care providers may harbor implicit, or unconscious, biases that contribute to health care disparities.
More states are expanding telehealth locations and broadening the pool of telemedicine providers, while fading out in-person requirements.
The uninsured more often reported material burdens; the insured reported more worry, distress, and frustration.
Two trends combine for an effective 212% increase in worker deductibles over the past decade.
Phoenix – By starting supportive measures early in the care of cancer patients undergoing curative treatment, a...
Huge bill to address the opioid epidemic contains many provisions that will affect physicians.